Implications for clinical practice, laboratory medicine and public health in Canada
Check out this collaborative work by representatives of the Canadian Public Health Laboratory Network, Canadian Society of Clinical Chemists, Association of Medical Microbiology and Infectious Disease Canada, Canadian Association for Clinical Microbiology and Infectious Diseases, & Canada’s COVID-19 Immunity Task Force, to provide guidance for the use of serological testing in Canada:
SARS-CoV-2 (COVID-19) Serology: A Review and Assessment of Potential Implications for Clinical Practice, Laboratory Medicine, and Public Health. Canadian Medical Association Journal. 2020;192(34):E973-E979.
Members of the Canadian Society of Clinical Chemists contributing to this work: Dana Bailey MSc PhD, Danijela Konforte PhD, Vilte E. Barakauskas PhD, Vathany Kulasingam, Lori Beach PhD, Ivan Blasutig PhD, Peter Catomeris PhD, Mari L. DeMarco PhD, Yanping Gong MD PhD, Peter A. Kavsak PhD, Ed Randell PhD, Julie Shaw, PhD, Jennifer Taher PhD, Nicole White-Al Habeeb PhD.